Canada · 
What does adMare Bio Innovations invest in?
adMare Bio Innovations invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Life Sciences.
adMare Bio Innovations highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Series A and Series B: 100% of its rounds
What they do
adMare partners with innovators and entrepreneurs to overcome early-stage hurdles and build a pipeline of strong, investable Canadian life sciences companiesFrom their own website
- Type
- Accelerator (from a list, unverified)
- Cheque size
- $200K – $8.0M as they say
- Stages
- Pre-seedSeedSeries ASeries BGrowth
- Sectors
- Life Sciences
- Based in
- Vancouver, Canada
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2026
2 rounds
- Nov
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
6 of 15 we have independently watched raise
EpitopeaFindtherapeuticsFlosonicsmedicalInversagoSpecificbiologicsZymeworks26therapeuticsArtelobioBrightangeltherapeuticsForustherapeuticsGskImmugeniaKisojibiotechOcytheraZucara
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.